Age of first cancer diagnosis and survival in Bloom syndrome.

[1]  S. Arron,et al.  Tumour predisposition and cancer syndromes as models to study gene–environment interactions , 2020, Nature Reviews Cancer.

[2]  Robert W. Taylor,et al.  Mutations in TOP3A Cause a Bloom Syndrome-like Disorder , 2018, American journal of human genetics.

[3]  A. Zauber,et al.  Health supervision for people with Bloom syndrome , 2018, American journal of medical genetics. Part A.

[4]  L. Strong,et al.  Cancer Screening Recommendations for Individuals with Li-Fraumeni Syndrome , 2017, Clinical Cancer Research.

[5]  D. Amor,et al.  Loss of RMI2 Increases Genome Instability and Causes a Bloom-Like Syndrome , 2016, PLoS genetics.

[6]  P. Rosenberg,et al.  Risks of first and subsequent cancers among TP53 mutation carriers in the National Cancer Institute Li‐Fraumeni syndrome cohort , 2016, Cancer.

[7]  N. Ellis,et al.  Bloom's Syndrome: Clinical Spectrum, Molecular Pathogenesis, and Cancer Predisposition , 2016, Molecular Syndromology.

[8]  A. Hoischen,et al.  Deleterious Germline BLM Mutations and the Risk for Early-onset Colorectal Cancer , 2015, Scientific Reports.

[9]  A. Antoniou,et al.  High prevalence and breast cancer predisposing role of the BLM c.1642 C>T (Q548X) mutation in Russia , 2012, International journal of cancer.

[10]  P. Rosenberg,et al.  Incidence of neoplasia in Diamond Blackfan anemia: a report from the Diamond Blackfan Anemia Registry. , 2012, Blood.

[11]  P. Rosenberg,et al.  Malignancies and survival patterns in the National Cancer Institute inherited bone marrow failure syndromes cohort study , 2010, British journal of haematology.

[12]  R. McGinnis,et al.  Irradiated Blm-deficient mice are a highly tumor prone model for analysis of a broad spectrum of hematologic malignancies. , 2010, Leukemia research.

[13]  R. Eeles,et al.  Surveillance and treatment of malignancy in Bloom syndrome. , 2008, Clinical oncology (Royal College of Radiologists (Great Britain)).

[14]  P. Rosenberg,et al.  Cancer incidence in persons with Fanconi anemia. , 2003, Blood.

[15]  N. Ellis,et al.  BLM, the Bloom’s syndrome protein, varies during the cell cycle in its amount, distribution, and co-localization with other nuclear proteins , 2001, Cytogenetic and Genome Research.

[16]  J. German.  Bloom's syndrome. XX. The first 100 cancers. , 1997, Cancer genetics and cytogenetics.

[17]  U. Lönn,et al.  Increased levels of 5‐fluorouracil‐induced dna lesions in bloom's syndrome , 1990, International journal of cancer.

[18]  E. Passarge,et al.  Bloom's Syndrome. XII. Report from the Registry for 1987 , 1989, Clinical genetics.

[19]  J. German,et al.  A manyfold increase in sister chromatid exchanges in Bloom's syndrome lymphocytes. , 1974, Proceedings of the National Academy of Sciences of the United States of America.

[20]  G. Deshors,et al.  Bloom's syndrome. , 1995, Dermatologic clinics.